# Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects

> **NCT01358435** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 53 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** 30% Regular Insulin Human Neutral and 70%Isophane Insulin
- **BIOLOGICAL:** Novolin 70/30

## Key facts

- **NCT ID:** NCT01358435
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2012-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01358435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01358435, "Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01358435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*